Repatriation Medical Authority - Declaration - Malignant Neoplasm of the Pancreas

Overview

The Veterans' Entitlements Act 1986 was enacted to provide a framework for the entitlements of veterans, their families, and dependants, addressing gaps in support and recognition of health issues arising from service. The Act aims to ensure that veterans and their families receive appropriate support and benefits. The Repatriation Medical Authority, as part of its mandate under the Act, reviews and amends Statements of Principles concerning various health conditions related to service. In this instance, the Authority reviewed the contents of the Statements of Principles regarding malignant neoplasm of the pancreas in light of new evidence related to exposure to DDT. Following an investigation, the Authority decided not to amend the Statement of Principles concerning malignant neoplasm of the pancreas regarding exposure to DDT due to insufficient new medical-scientific evidence. However, it did propose to reword a factor concerning exposure to DDT in another Statement of Principles to better reflect the current understanding of the condition. This decision underscores the Authority's commitment to basing its determinations on the most reliable and up-to-date medical-scientific evidence available.

Scope and Application

The Veterans’ Entitlements Act 1986 applies to veterans and their families who seek entitlements due to service-related disabilities or deaths. This Act governs the provision of various benefits and services to eligible individuals, including financial support, medical care, and rehabilitation. The scope of the Act encompasses persons who have served in the Australian Defence Force, including those who served in war or peacetime operations, and their dependents. The Act operates within the Commonwealth jurisdiction and applies across Australia, ensuring that eligible veterans and their families can access the necessary support regardless of where they reside. The Act extends its application through various subordinate instruments, which provide detailed guidelines and criteria for the assessment and determination of entitlements. In relation to the specific declaration concerning malignant neoplasm of the pancreas and exposure to DDT, the Repatriation Medical Authority is tasked with reviewing Statements of Principles concerning veterans' health issues. The Authority's findings are based on new medical-scientific evidence and determine whether amendments to the Statements of Principles are warranted. In this instance, the Authority has decided not to amend Instrument No. 74 of 2013 but has proposed a rewording of Instrument No. 73 of 2013 to better clarify the relationship between exposure to DDT and malignant neoplasm of the pancreas. The decision not to extend the amendment to Instrument No. 74 is due to insufficient evidence to establish a more probable than not relationship.

Key Provisions

The main sections of this declaration pertain to the review of Statements of Principles concerning malignant neoplasm of the pancreas under the Veterans’ Entitlements Act 1986 (section 196B(9)). This review specifically addresses the exposure to DDT, as detailed in the Notice of Investigation published in the Government Notices Gazette on 9 January 2018. According to this review, the Repatriation Medical Authority (the Authority) has decided not to amend Statement of Principles Instrument No. 74 of 2013. This decision is based on the assessment that the new medical-scientific evidence available is insufficient to warrant such an amendment. Conversely, the Authority has decided to amend Statement of Principles Instrument No. 73 of 2013 by rewording factor 6(e) concerning exposure to DDT, in light of new evidence that raises a reasonable hypothesis about the potential link between malignant neoplasm of the pancreas and exposure to DDT during service. However, the Authority has not concluded that this relationship is more probable than not, and therefore, has not amended Instrument No. 74 of 2013. The obligations imposed by the Act on the Authority include the responsibility to review the Statements of Principles concerning malignant neoplasm of the pancreas in light of new medical-scientific evidence. This involves conducting an investigation, as evidenced by the Notice of Investigation published in the Government Notices Gazette. The Authority must also make a determination as to whether the new evidence is sufficient to warrant amendments to the Statements of Principles. In this instance, the Authority has chosen not to amend Instrument No. 74 of 2013 but has decided to reword factor 6(e) in Instrument No. 73 of 2013. The Authority must ensure that these decisions are made in accordance with the provisions of the Act and are supported by sound medical-scientific evidence. The Act does not specify any offences, penalties, or civil/criminal consequences for breaches directly related to the Authority's decision-making process concerning the Statements of Principles. However, the Authority must adhere to the requirements of the Act when making its determinations. Failure to comply with these requirements could potentially result in legal challenges or administrative reviews. The Authority must ensure that its decisions are well-founded and transparent, thereby upholding the integrity of the review process. The specific maximum penalties for any breaches of the Act are not outlined in the text of this declaration, but they would be determined by the relevant legal frameworks and any associated regulations.